Book contents
- Frontmatter
- Preface
- Contents
- Continuing Medical Education (CME) Information
- Objectives
- Chapter 1 Neurobiology of Stress and Anxiety
- Chapter 2 Posttraumatic Stress Disorder (PTSD)
- Chapter 3 Neurotransmitter Systems as Pharmacological Targets for PTSD
- Chapter 4 First-Line Medications for PTSD
- Chapter 5 Second-Line, Adjunct, and Investigational Medications for PTSD
- Chapter 6 Cognitive Behavioral Therapy (CBT) for PTSD
- Chapter 7 Caring for Patients with PTSD
- Chapter 8 Unique Considerations for the Military Population
- Summary
- Abbreviations
- Suggested Readings
- Index
- CME: Posttest and Certificate
Summary
Published online by Cambridge University Press: 19 October 2021
- Frontmatter
- Preface
- Contents
- Continuing Medical Education (CME) Information
- Objectives
- Chapter 1 Neurobiology of Stress and Anxiety
- Chapter 2 Posttraumatic Stress Disorder (PTSD)
- Chapter 3 Neurotransmitter Systems as Pharmacological Targets for PTSD
- Chapter 4 First-Line Medications for PTSD
- Chapter 5 Second-Line, Adjunct, and Investigational Medications for PTSD
- Chapter 6 Cognitive Behavioral Therapy (CBT) for PTSD
- Chapter 7 Caring for Patients with PTSD
- Chapter 8 Unique Considerations for the Military Population
- Summary
- Abbreviations
- Suggested Readings
- Index
- CME: Posttest and Certificate
Summary
• Anxiety and fear are normal responses to stressors
• The emotional, behavioral, and physical manifestations of anxiety and fear are mediated in large part by amygdala-centered circuits
• Pathological anxiety may develop when repeated stressors and genetic vulnerabilities combine and lead to stress-sensitization within those circuits
• Posttraumatic stress disorder (PTSD) is a particularly prevalent disorder with significant functional consequences
• First-line treatment options for PTSD include cognitive behavioral therapy (CBT—exposure, cognitive restructuring), selective serotonin reuptake inhibitors, and serotonin norepinephrine reuptake inhibitors
• There are also many second-line and adjunct treatment options (pharmacological and non-pharmacological)
• Most patients with PTSD have at least one comorbid disorder, which can affect treatment decisions
• Military personnel face unique circumstances that put them at particular risk for PTSD
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2010